NCT05695430 Brief Cognitive Behavioral Therapy for People With Physical Disabilities
| NCT ID | NCT05695430 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Suicide |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-03-01 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2022-03-01 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to examine the effectiveness of a psychotherapy (non-medication) treatment, Brief Cognitive Behavioral Therapy for Suicide Prevention, in reducing suicide ideation and attempts for people with physical disabilities.
Eligibility Criteria
Inclusion Criteria: * 18 years of age * Disability impacting vision, hearing, or mobility * Past-week suicidal ideation or past-month suicide attempt Exclusion Criteria: * Inability to provide informed consent * Lack of internet connection and web camera
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05695430 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05695430 currently recruiting?
Yes, NCT05695430 is actively recruiting participants. Contact the research team at lauren.khazem@osumc.edu for enrollment information.
Where is the NCT05695430 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT05695430 clinical trial?
NCT05695430 is sponsored by Ohio State University. The trial plans to enroll 60 participants.